Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disorders

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Expert Opinion on Biological Therapy

• Publication date

  2003-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14712598.3.7.1041PMID 14519069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autologous Stem Cell Transplantation in Progressive Multiple Sclerosis—An Interim Analysis of Efficacy

  2004cited by this paper
• Stem cells engineered to express self-antigen to treat autoimmunity.

  2003cited by this paper
• High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease.

  2003cited by this paper
• Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review.

  2003cited by this paper
• Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I–II study

  2002cited by this paper
• A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.

  2002cited by this paper
• Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.

  2002cited by this paper
• Autologous stem cell transplantation in the treatment of refractory rheumatoid arthritis.

  2002cited by this paper
• Predicting Mortality in Systemic Sclerosis: Analysis of a Cohort of 309 French Canadian Patients with Emphasis on Features at Diagnosis as Predictive Factors for Survival

  2002cited by this paper
• High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.

  2002cited by this paper
• Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: a case report.

  2002cited by this paper
• High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.

  2001cited by this paper
• Autoimmune diseases.

  2001cited by this paper
• The heart remembers: clinical implications.

  2001cited by this paper
• Treatment of autoimmune diseases by hematopoietic stem cell transplantation.

  2001cited by this paper
• Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease

  2001cited by this paper
• Autologous stem cell transplantation for rapidly progressive jo‐1‐positive polymyositis with long‐term follow‐up

  2001cited by this paper
• Autologous stem cell transplantation for rheumatoid arthritis--interim report of 6 patients.

  2001cited by this paper
• Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue

  2001cited by this paper
• Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience.

  2001cited by this paper
• Stem cell transplantation for autoimmune diseases.

  2001cited by this paper
• Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

  2001cited by this paper
• Relapse of systemic lupus erythematosus.

  2001cited by this paper
• Intense immunosuppression followed by purified blood CD34+ cell autografting in a patient with refractory juvenile rheumatoid arthritis

  2001cited by this paper
• Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus.

  2001cited by this paper
• Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease.

  2000cited by this paper
• High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis

  2000cited by this paper
• Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells

  2000cited by this paper
• Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation

  2000cited by this paper
• Prolonged remission state of refractory adult onset Still's disease following CD34-selected autologous peripheral blood stem cell transplantation

  2000cited by this paper
• Stem Cell Transplantation in Experimental Models of Autoimmune Disease

  2000cited by this paper
• Autologous peripheral blood stem cell transplantation in a patient with severe mixed connective tissue disease

  2000cited by this paper
• Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus

  2000cited by this paper
• Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring.

  2000cited by this paper
• Autoimmune diseases

  2000cited by this paper
• Effective treatment of Jo‐1‐associated polymyositis with T‐cell‐depleted autologous peripheral blood stem cell transplantation

  2000cited by this paper
• Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood

  1999cited by this paper
• Haemopoietic stem-cell transplantation for juvenile chronic arthritis.

  1999cited by this paper
• Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma.

  1999cited by this paper
• Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit.

  1999cited by this paper
• High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.

  1999cited by this paper
• High-Dose Chemotherapy and Syngeneic Hemopoietic Stem-Cell Transplantation for Severe, Seronegative Rheumatoid Arthritis

  1999cited by this paper
• Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis.

  1999cited by this paper
• Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis.

  1999cited by this paper
• T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients

  1998cited by this paper
• Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans Syndrome

  1998cited by this paper
• Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis.

  1998cited by this paper
• Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration

  1997cited by this paper
• Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation.

  1997cited by this paper
• Autologous stem cell transplantation for autoimmune diseases: issues in protocol development.

  1997cited by this paper
• Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT).

  1997cited by this paper
• Blood and marrow stem cell transsplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)

  1997cited by this paper
• Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year followup.

  1996cited by this paper
• Pathogenesis of scleroderma. Collagen.

  1996cited by this paper
• Immunopathogenesis of systemic sclerosis.

  1996cited by this paper
• Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease.

  1996cited by this paper
• Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor.

  1996cited by this paper
• Haemopoietic precursorcell transplants for autoimmune diseases

  1995cited by this paper
• Techniques for autologous transplants

  1995cited by this paper
• Selective abnormalities in the thymic microenvironment associated with avian scleroderma, an inherited fibrotic disease of L200 chickens.

  1991cited by this paper
• Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation.

  1991cited by this paper
• Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft.

  1982cited by this paper
• Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice.

  1974cited by this paper
• Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains.

  1969cited by this paper

• Ab Initio and DFT Study on Cyclophosphamide: Anticancer and Immunomodulating Agents

  2018cites this paper
• Multiple Sclerosis: Perspectives in Treatment and Pathogenesis

  2017influential citation
• Stem Cell Therapy - Approach for Multiple Sclerosis Treatment

  2016cites this paper
• Chapter 13 – Pharmacology: Biologics

  2016cites this paper
• Interstitial lung disease in systemic sclerosis: where do we stand?

  2015cites this paper
• Immunologic and oncological safety of autologous and allogenic mesenchymal bone marrow stromal cells

  2014cites this paper
• Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?

  2014cites this paper
• Immunosuppression for interstitial lung disease in systemic sclerosis

  2013cites this paper
• Feasibility of Cell Therapy in Multiple Sclerosis: A Systematic Review of 83 Studies

  2013cites this paper
• B cells in systemic sclerosis: a possible target for therapy.

  2011cites this paper
• PHARMACOLOGY AND DRUG THERAPY

  2011cites this paper
• Cyclophosphamide‐evoked heart failure involves pronounced co‐suppression of cytoplasmic thioredoxin reductase activity and non‐protein free thiol level

  2009cites this paper
• Autologous hematopoietic stem cell transplantation in autoimmune diseases

  2009cites this paper
• Autologous stem cell transplantation improves microcirculation in systemic sclerosis

  2008cites this paper
• Interstitial Lung Disease in Systemic Sclerosis

  2007cites this paper
• Facilitating cells: novel promoters of stem cell alloengraftment and donor-specific transplantation tolerance in the absence of GVHD.

  2007cites this paper
• Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis

  2006cites this paper
• Mechanisms and consequences of fibrosis in systemic sclerosis

  2006cites this paper
• Therapeutic interleukin (IL) 1 blockade normalises increased IL1 beta and decreased tumour necrosis factor alpha and IL10 production in blood mononuclear cells of a patient with CINCA syndrome.

  2005cites this paper
• Untersuchungen zur Bedeutung mesenchymaler Stammzellen in der Geweberegeneration

  2005cites this paper
• Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance

  2005cites this paper
• Reversible posterior leucoencephalopathy in scleroderma

  2005cites this paper
• Haematopoietic stem cell transplantation for autoimmune disease: limits and future potential.

  2004cites this paper
• Transmission of donor illness by stem cell transplantation: should screening be different in older donors?

  2004cites this paper
• Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.

  2004cites this paper
• ORIGINAL ARTICLE

  2001cites this paper